EKF Diagnostics Showcases Latest Data Management Solutions
|
By LabMedica International staff writers Posted on 05 Feb 2018 |
|
The DiaSpect Tm hemoglobin analyzer (Photo courtesy of EKF Diagnostics).
EKF Diagnostics (Cardiff, UK) showcased its latest data management solutions for the DiaSpect Tm hemoglobin analyzer and Quo-Test HbA1c analyzer at MEDLAB Middle East 2018 held in Dubai, UAE from February 5-8, 2018.
EKF was among the exhibitors at the event who showcased the latest innovations, products and cutting-edge technologies available in the IVD, medical laboratory and healthcare market. Among the company’s range of Point of Care (POC) hemoglobin analyzers displayed at MEDLAB Middle East were Hemo Control, DiaSpect Tm and HemataStat II. The Hemo Control POC hemoglobin analyzer is designed to provide quantitative, lab quality hemoglobin results from 25 seconds and is used in blood banks, hospitals and doctors’ offices for routine screening for anemia. The company’s DiaSpect Tm is the world’s fastest hemoglobin analyzer. DiaSpect Tm and delivers laboratory quality results in just about one second of the microcuvette being placed into the analyzer. The HemataStat II is a microhematocrit centrifuge that provides a quantitative hematocrit reading for up to six blood samples from one 60 second spin.
Among EKF’s range of POC diabetes analyzers on display at this year’s MEDLAB Middle East was Quo-Lab, Quo-Test, Biosen and STAT-Site M BHB. The Quo-Lab HbA1c is a semi-automated desktop analyzer for measuring glycated hemoglobin (HbA1c), while the Quo-Test HbA1c system is a fully automated hemoglobin A1c analyzer. The Biosen series of glucose analyzers include three different models and can be manufactured as single channel glucose systems or as dual channel systems that can measure lactate at the same time. The STAT-Site M BHB analyzer is used for the quantitative determination of B-Hydroxybutyrate (Beta-Hydroxybutyrate or BHB) in serum or plasma. EKF also displayed products for maternal & women’s health, including the Creamatocrit Plus POC analyzer and pregnancy tests.
At MEDLAB Middle East 2018, EKF also showcased products from its Central Laboratory division, which included the Stanbio Chemistry range of reagents, controls, calibrators and standards and its own range of benchtop lab analyzers.
Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
Laboratory Software
ArtelWare
Gold Member
Collection and Transport System
PurSafe Plus®
Latest MEDLAB 2018 News
- Snibe Diagnostic Displays Analyzers at MEDLAB Europe 2018
- MEDLAB Europe 2018 Presents Latest Technologies and Developments
- MedLab Middle East Continues as World's Largest Attended Laboratory Exhibition and Conference
- Fujifilm Showcases DRI-CHEM NX700 Dry Chemistry Analyzer
- Zeesan Biotech Displays DNA Automated Extraction System
- Priorclave Highlights Its Smallest Steam Sterilizer
- HORIBA Medical Launches HELO and Yumizen G Range
- Astell Scientific Showcases Latest Autoclave Range
- AXA Diagnostics Highlights SkyLAB752 System
- Block Scientific Showcases Medical Lab Equipment Devices
- BIOBASE Displays Range Of Laboratory & Medical Analyzers
- Siemens Healthineers Showcases Advanced Diagnostics Analyzers
Channels
Clinical Chemistry
view channel
Blood Test Could Predict and Identify Early Relapses in Myeloma Patients
Multiple myeloma is an incurable cancer of the bone marrow, and while many patients now live for more than a decade after diagnosis, a significant proportion relapse much earlier with poor outcomes.... Read more
Compact Raman Imaging System Detects Subtle Tumor Signals
Accurate cancer diagnosis often depends on labor-intensive tissue staining and expert pathological review, which can delay results and limit access to rapid screening. These conventional methods also make... Read more
Molecular Diagnostics
view channel
Blood Metabolite Signature Test Better Predicts Type 2 Diabetes Risk
Type 2 diabetes is rising worldwide and now accounts for more than 90% of all diabetes cases, driven by impaired insulin response and long-term metabolic dysfunction. The disease often develops silently... Read more
Genetic Test Could Detect Predisposition to Pancreatic Cancer
Pancreatic ductal adenocarcinoma is one of the deadliest cancers, largely because it is usually diagnosed at an advanced stage when treatment options are limited. The lack of effective population screening... Read more
Hematology
view channel
AI Algorithm Effectively Distinguishes Alpha Thalassemia Subtypes
Alpha thalassemia affects millions of people worldwide and is especially common in regions such as Southeast Asia, where carrier rates can reach extremely high levels. While the condition can have significant... Read more
MRD Tests Could Predict Survival in Leukemia Patients
Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Immunology
view channel
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read more
Microbiology
view channel
New Test Measures How Effectively Antibiotics Kill Bacteria
Antibiotics are typically evaluated by how well they inhibit bacterial growth in laboratory tests, but growth inhibition does not always mean the bacteria are actually killed. Some pathogens can survive... Read more
New Antimicrobial Stewardship Standards for TB Care to Optimize Diagnostics
Antibiotic resistance is rising worldwide, threatening the effectiveness of treatments for major infectious diseases, including tuberculosis (TB). Resistance to key TB drugs, such as bedaquiline, is of... Read more
Pathology
view channel
Intraoperative Tumor Histology to Improve Cancer Surgeries
Surgical removal of cancer remains the first-line treatment for many tumors, but ensuring that all cancerous tissue is removed while preserving healthy tissue is a major challenge. Surgeons currently rely... Read more
Rapid Stool Test Could Help Pinpoint IBD Diagnosis
Inflammatory bowel disease (IBD) is a chronic condition in which the immune system mistakenly attacks the digestive tract, causing persistent gut inflammation. Diagnosis and disease monitoring often depend... Read more
AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery
Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Technology
view channel
Aptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read more
Industry
view channel
WHX Labs Dubai to Gather Global Experts in Antimicrobial Resistance at Inaugural AMR Leaders’ Summit
World Health Expo (WHX) Labs in Dubai (formerly Medlab Middle East), which will be held at Dubai World Trade Centre from 10-13 February, will address the growing global threat of antimicrobial resistance... Read more
